InvestorsHub Logo
Followers 26
Posts 1574
Boards Moderated 0
Alias Born 12/03/2009

Re: None

Friday, 01/18/2019 10:27:34 AM

Friday, January 18, 2019 10:27:34 AM

Post# of 200073
"We strive to become a leader in immuno-therapeutic treatment and prevention of HIV/AIDS, Cancer and other immuno related disorders."

Our flagship compound ITV-1, which studies have shown is effective in the treatment of HIV/AIDS and Hepatitis C viruses and to modulate the immune system.

Check company's website http://www.enzolytics.com/ there is lots of very interesting info. $ENZC
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News